BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10343158)

  • 1. No quantitative relationship between CR1 and Lutheran expression on erythrocytes: In(Lu) gene product is not a common regulator of CR1 expression on erythrocytes.
    Oudin S; Lepennec PY; Dervillez X; Tonye-Libyh M; Tabary T; Philbert F; Bougy F; Reveil B; Pennaforte JL; Rouger P; Cohen JH
    Exp Clin Immunogenet; 1999; 16(2):72-80. PubMed ID: 10343158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients.
    Lach-Trifilieff E; Marfurt J; Schwarz S; Sadallah S; Schifferli JA
    J Immunol; 1999 Jun; 162(12):7549-54. PubMed ID: 10358211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
    Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
    Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement receptor 1 red cell expression is not controlled by the In(Lu) gene.
    Moulds JM; Shah C
    Transfusion; 1999 Jul; 39(7):751-5. PubMed ID: 10413284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
    Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
    Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
    Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
    Complement; 1986; 3(2):88-96. PubMed ID: 2945697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35).
    Hebert LA; Birmingham DJ; Dillon JJ; Cosio FG; Shen XP
    J Am Soc Nephrol; 1994 Apr; 4(10):1786-91. PubMed ID: 8068876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
    Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
    J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
    Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
    Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    Iida K; Mornaghi R; Nussenzweig V
    J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody.
    Minota S; Terai C; Nojima Y; Takano K; Takai E; Miyakawa Y; Takaku F
    Arthritis Rheum; 1984 Dec; 27(12):1329-35. PubMed ID: 6239627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.
    Birmingham DJ; Gavit KF; McCarty SM; Yu CY; Rovin BH; Nagaraja HN; Hebert LA
    Clin Exp Immunol; 2006 Feb; 143(2):274-80. PubMed ID: 16412051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
    Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
    Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.